Scienture (SCNX) Competitors $2.16 -0.32 (-12.90%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsTrends SCNX vs. NHTC, HWH, RAVE, SAG, BANL, LTCH, HYFM, DTCK, GDC, and HKPDShould you be buying Scienture stock or one of its competitors? The main competitors of Scienture include Natural Health Trends (NHTC), HWH International (HWH), Rave Restaurant Group (RAVE), SAG (SAG), CBL International (BANL), Latch (LTCH), Hydrofarm Holdings Group (HYFM), Davis Commodities (DTCK), GD Culture Group (GDC), and Hong Kong Pharma Digital Technology (HKPD). These companies are all part of the "wholesale" industry. Scienture vs. Natural Health Trends HWH International Rave Restaurant Group SAG CBL International Latch Hydrofarm Holdings Group Davis Commodities GD Culture Group Hong Kong Pharma Digital Technology Natural Health Trends (NASDAQ:NHTC) and Scienture (NASDAQ:SCNX) are both small-cap consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, community ranking, risk, analyst recommendations, earnings, dividends and profitability. Does the media prefer NHTC or SCNX? In the previous week, Natural Health Trends had 2 more articles in the media than Scienture. MarketBeat recorded 3 mentions for Natural Health Trends and 1 mentions for Scienture. Scienture's average media sentiment score of 1.87 beat Natural Health Trends' score of 1.08 indicating that Scienture is being referred to more favorably in the news media. Company Overall Sentiment Natural Health Trends Positive Scienture Very Positive Which has more risk & volatility, NHTC or SCNX? Natural Health Trends has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Scienture has a beta of 2.28, indicating that its stock price is 128% more volatile than the S&P 500. Do insiders & institutionals have more ownership in NHTC or SCNX? 10.1% of Natural Health Trends shares are owned by institutional investors. Comparatively, 5.7% of Scienture shares are owned by institutional investors. 13.3% of Natural Health Trends shares are owned by company insiders. Comparatively, 49.7% of Scienture shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor NHTC or SCNX? Natural Health Trends received 197 more outperform votes than Scienture when rated by MarketBeat users. CompanyUnderperformOutperformNatural Health TrendsOutperform Votes19769.86% Underperform Votes8530.14% ScientureN/AN/A Which has stronger earnings and valuation, NHTC or SCNX? Natural Health Trends has higher revenue and earnings than Scienture. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Health Trends$42.96M1.37$570K$0.0685.50Scienture$7.12M2.68-$17.84MN/AN/A Is NHTC or SCNX more profitable? Natural Health Trends has a net margin of 1.33% compared to Scienture's net margin of 0.00%. Natural Health Trends' return on equity of 1.53% beat Scienture's return on equity.Company Net Margins Return on Equity Return on Assets Natural Health Trends1.33% 1.53% 0.92% Scienture N/A -77.60%-62.29% SummaryNatural Health Trends beats Scienture on 8 of the 12 factors compared between the two stocks. Get Scienture News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCNX vs. The Competition Export to ExcelMetricScienturePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.06M$7.20B$5.80B$8.36BDividend YieldN/A2.80%4.76%3.97%P/E RatioN/A6.1924.9419.10Price / Sales2.68188.78374.85113.79Price / CashN/A65.6738.0534.62Price / Book4.716.417.314.26Net Income-$17.84M$139.72M$3.19B$246.62M7 Day Performance-17.83%-3.51%-3.22%-3.86%1 Month Performance-42.31%-9.28%-7.05%-6.97%1 Year PerformanceN/A-12.82%12.17%3.33% Scienture Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCNXScientureN/A$2.12-14.5%N/AN/A$19.06M$7.12M0.00N/APositive NewsNHTCNatural Health Trends1.0474 of 5 stars$4.77+0.5%N/A-17.0%$55.21M$42.96M79.93140Analyst ForecastShort Interest ↑Positive NewsHWHHWH InternationalN/A$1.61-6.9%N/A-69.4%$50.12MN/A0.00N/ARAVERave Restaurant Group1.5526 of 5 stars$2.86-0.3%N/A+56.6%$42.08M$12.24M15.8920Analyst ForecastNews CoverageGap DownSAGSAGN/A$3.01+23.0%N/AN/A$29.29MN/A0.00N/AHigh Trading VolumeBANLCBL International0.9421 of 5 stars$0.98-3.9%N/A-2.8%$26.95M$435.90M0.0035Short Interest ↓Gap DownLTCHLatchN/A$0.16flatN/A-72.2%$25.75M$42.96M0.00420Gap DownHYFMHydrofarm Holdings Group3.921 of 5 stars$5.44-4.7%$7.00+28.7%-49.5%$25.11M$200.16M-0.39840Upcoming EarningsGap DownDTCKDavis Commodities1.2118 of 5 stars$0.91-0.7%N/A+1.0%$22.27M$159.84M0.0022Short Interest ↓GDCGD Culture Group1.2097 of 5 stars$1.86+22.0%N/A-12.5%$20.27M$-150,000.000.0060Short Interest ↓Gap DownHigh Trading VolumeHKPDHong Kong Pharma Digital TechnologyN/A$1.75+1.2%N/AN/A$19.25M$16.69M0.0019Positive NewsGap Down Related Companies and Tools Related Companies NHTC Competitors HWH Competitors RAVE Competitors SAG Competitors BANL Competitors LTCH Competitors HYFM Competitors DTCK Competitors GDC Competitors HKPD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCNX) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scienture Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scienture With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.